| NDC Code | 50114-7050-1 |
|---|
| Package Description | 10 VIAL in 1 CARTON (50114-7050-1) > 2.2 mL in 1 VIAL |
|---|
| Product NDC | 50114-7050 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Cutis Compositum |
|---|
| Non-Proprietary Name | Ledum Palustre Twig And Urtica Urens And Aesculus Hippocastanum Flower And Galium Aparine And Strychnos Ignatii Seed And Arctium Lappa Root And Phosphoric Acid And Sus Scrofa Skin And Thuja Occidentalis Leafy Twig And Fumaric Acid And Sus Scrofa Umbilical Cord And Sus Scrofa Adrenal Gland And Pork Liver And .alpha.-ketoglutaric Acid And Sodium Diethyl Oxalacetate And Sus Scrofa Placenta And Selenium And Sus Scrofa Spleen |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20090430 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Heel Inc |
|---|
| Substance Name | .ALPHA.-KETOGLUTARIC ACID; AESCULUS HIPPOCASTANUM FLOWER; ARCTIUM LAPPA ROOT; CALCIUM FLUORIDE; CORTISONE ACETATE; FORMIC ACID; FUMARIC ACID; GALIUM APARINE; ICHTHAMMOL; LEDUM PALUSTRE TWIG; MERCURIUS SOLUBILIS; PHOSPHORIC ACID; PORK LIVER; SELENIUM; SODIUM DIETHYL OXALACETATE; STRYCHNOS IGNATII SEED; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA PLACENTA; SUS SCROFA SKIN; SUS SCROFA SPLEEN; SUS SCROFA UMBILICAL CORD; THALLIUM SULFATE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS |
|---|
| Strength | 10; 6; 6; 13; 28; 198; 10; 6; 28; 4; 13; 6; 10; 10; 10; 6; 10; 10; 10; 8; 10; 10; 13; 8; 4 |
|---|
| Strength Unit | [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL |
|---|
| Pharmacy Classes | Non-Standardized Animal Skin Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
|---|